Vigil B. Characterizing a Novel Engineered Therapeutic Agent to Reverse Lupus Symptoms. URJ-UCCS [Internet]. 2020 Jul. 13 [cited 2024 May 6];13(2). Available from: https://urj.uccs.edu/index.php/urj/article/view/511